Is Standard Biotools Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: LAB) stock is to Strong Buy LAB stock.
Out of 1 analyst, 1 (100%) are recommending LAB as a Strong Buy, 0 (0%) are recommending LAB as a Buy, 0 (0%) are recommending LAB as a Hold, 0 (0%) are recommending LAB as a Sell, and 0 (0%) are recommending LAB as a Strong Sell.
According to 1 Wall Street analyst that have issued a 1 year LAB price target, the average LAB price target is $10.00, with the highest LAB stock price forecast at $10.00 and the lowest LAB stock price forecast at $10.00.
The Wall Street analyst predicted that Standard Biotools's share price could reach $10.00 by Aug 9, 2022. The average Standard Biotools stock price prediction forecasts a potential upside of 392.61% from the current LAB share price of $2.03.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.